ImmunoPrecise Antibodies Ltd. (HYFT) — Financial Flexibility Index
ImmunoPrecise Antibodies Ltd. (HYFT) has a Financial Flexibility Index of -0.33x as of October 2025. Free cash flow of $-2.80 Million (operating CF $-2.87 Million minus capex $74.00K) represents 0% of total liabilities ($8.40 Million). Check cash flow reinvestment rate of ImmunoPrecise Antibodies Ltd. to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ImmunoPrecise Antibodies Ltd. Financial Flexibility Index (1997–2025)
Historical Financial Flexibility Index trend for ImmunoPrecise Antibodies Ltd. across 29 annual periods. For the full cash flow conversion analysis, see ImmunoPrecise Antibodies Ltd. operating cash flow efficiency.
Annual Financial Flexibility Index for ImmunoPrecise Antibodies Ltd. (1997–2025)
Year-by-year free cash flow to debt coverage for ImmunoPrecise Antibodies Ltd.. Explore how well can ImmunoPrecise Antibodies Ltd. service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.27x | $-5.61 Million | $-6.41 Million | $20.82 Million | ▼ -146.6% |
| 2024 | -0.11x | $-2.85 Million | $-4.25 Million | $26.07 Million | ▲ +88.1% |
| 2023 | -0.92x | $-18.34 Million | $-19.83 Million | $20.01 Million | ▼ -94.2% |
| 2022 | -0.47x | $-8.66 Million | $-9.92 Million | $18.36 Million | ▼ -672.5% |
| 2021 | 0.08x | $827.00K | $-600.00K | $10.04 Million | ▲ +223.0% |
| 2020 | -0.07x | $-815.65K | $-1.39 Million | $12.18 Million | ▲ +73.1% |
| 2019 | -0.25x | $-2.56 Million | $-3.21 Million | $10.28 Million | ▲ +3.6% |
| 2018 | -0.26x | $-3.07 Million | $-3.42 Million | $11.87 Million | ▼ -13.4% |
| 2017 | -0.23x | $-190.90K | $-721.65K | $836.91K | ▼ -135.7% |
| 2016 | 0.64x | $301.57K | $284.09K | $472.15K | ▲ +1130.0% |
| 2015 | -0.06x | $-15.79K | $-36.11K | $254.64K | ▲ +59.6% |
| 2014 | -0.15x | $-46.60K | $-46.60K | $303.50K | ▼ -840.9% |
| 2013 | -0.02x | $-4.33K | $-4.33K | $265.63K | ▲ +97.3% |
| 2012 | -0.62x | $-131.08K | $-132.72K | $213.10K | ▲ +21.5% |
| 2011 | -0.78x | $-66.73K | $-80.39K | $85.19K | ▼ -649.7% |
| 2010 | 0.14x | $14.32K | $-308.49K | $100.47K | ▼ -98.3% |
| 2009 | 8.18x | $1.23 Million | $-155.68K | $150.84K | ▲ +173.2% |
| 2008 | -11.17x | $-418.41K | $-523.45K | $37.46K | ▼ -214.0% |
| 2007 | 9.80x | $1.53 Million | $-297.31K | $155.85K | ▼ -21.8% |
| 2006 | 12.53x | $1.74 Million | $-110.59K | $138.62K | ▼ -24.0% |
| 2005 | 16.48x | $777.57K | $-82.20K | $47.18K | ▲ +957.4% |
| 2004 | 1.56x | $77.81K | $-178.69K | $49.92K | ▲ +231.8% |
| 2003 | -1.18x | $-18.95K | $-168.38K | $16.02K | ▲ +18.2% |
| 2002 | -1.45x | $-271.35K | $-280.23K | $187.72K | ▼ -287.2% |
| 2001 | 0.77x | $692.26K | $-8.13K | $896.75K | ▲ +114.4% |
| 2000 | -5.37x | $-54.30K | $-208.54K | $10.11K | ▼ -217.0% |
| 1999 | 4.59x | $164.24K | $-202.94K | $35.78K | ▼ -63.7% |
| 1998 | 12.65x | $852.70K | $-226.81K | $67.39K | ▲ +668.4% |
| 1997 | 1.65x | $411.71K | $-108.20K | $250.04K | — |